Aldeyra Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Lexington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Aldeyra Therapeutics, Inc. has filed 645 SEC EDGAR filings since 06 Oct 2005

SEC filing history

Showing 301-325 of 643 matching filings.

Per page
25
Current page
13
SC 13G/A File 005-88182

ALDEYRA THERAPEUTICS, INC.

Filing date
12 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88182

SC 13G/A filing

Filing date
07 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88182

SC 13G filing

Filing date
07 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jan 2020
Reporting date
13 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
15 Jan 2020
Reporting date
13 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

8-K

Filing date
14 Jan 2020
Reporting date
13 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88182

SCHEDULE 13G-A FOR ALDEYRA THERAPEUTICS, INC. BY DOMAIN PARTNERS VI, L.P.

Filing date
10 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Dec 2019
Reporting date
16 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

8-K

Filing date
03 Dec 2019
Reporting date
03 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

8-K

Filing date
07 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

8-K

Filing date
31 Oct 2019
Reporting date
31 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Oct 2019
Reporting date
30 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88182

ALDEYRA THERAPEUTICS, INC.

Filing date
27 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Sep 2019
Reporting date
23 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

8-K

Filing date
24 Sep 2019
Reporting date
24 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Sep 2019
Reporting date
18 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Sep 2019
Reporting date
17 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
17 Sep 2019
Reporting date
13 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Sep 2019
Reporting date
13 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Sep 2019
Reporting date
13 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Sep 2019
Reporting date
11 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Sep 2019
Reporting date
09 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Sep 2019
Reporting date
09 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .